TRACON Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- TRACON Pharmaceuticals's estimated annual revenue is currently $7.8M per year.
- TRACON Pharmaceuticals's estimated revenue per employee is $155,000
Employee Data
- TRACON Pharmaceuticals has 50 Employees.
- TRACON Pharmaceuticals grew their employee count by 2% last year.
TRACON Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | Sr VP, Regulatory Affairs | Reveal Email/Phone |
2 | CFO | Reveal Email/Phone |
3 | SVP | Reveal Email/Phone |
4 | VP, Statistics and Bioinformatics | Reveal Email/Phone |
5 | Associate Director IT | Reveal Email/Phone |
6 | Executive Director, Statistical Programming | Reveal Email/Phone |
7 | Chief Business Officer | Reveal Email/Phone |
8 | Chief Medical Officer | Reveal Email/Phone |
9 | Chief Operating Officer | Reveal Email/Phone |
10 | Administration and HR Manager | Reveal Email/Phone |
TRACON Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is TRACON Pharmaceuticals?
N/A
Total Funding
50
Number of Employees
$7.8M
Revenue (est)
2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
TRACON Pharmaceuticals News
2022-04-17 - TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Major ...
TRACON Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer in the...
2022-04-17 - TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) CEO ...
TRACON Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer in the...
2022-04-13 - Tracon Pharmaceuticals Gets Approval for Envasarc at All Clinical Sites
By Chris Wack. Tracon Pharmaceuticals Inc. said its amended Envasarc protocol, approved by the U.S. Food and Drug Administration in February...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $10.8M | 50 | 0% | N/A |
#2 | $9.8M | 50 | -15% | N/A |
#3 | $3.5M | 50 | 0% | N/A |
#4 | $11M | 50 | 0% | N/A |
#5 | $7.2M | 50 | 4% | N/A |